From professional translators, enterprises, web pages and freely available translation repositories.
cpmp/ bpwg/ 282/ 00
cpmp/bpwg/282/00
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
emea/cpmp/bpwg/198/95
leitlinien/stand
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
werkgroep bloed en plasma (bpwg)
arbeitsgruppe blut und plasma (bpwg)
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
referentienummer emea/cpmp/bpwg/283/00
dokumentennummer emea/cpmp/bpwg/283/00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/bpwg/198/95 rev.1
86 emea allgemeiner tätigkeitsbericht 2000
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
cpmp/ bpwg/ 3226/ 99 cpmp/ bpwg/ 283/ 00
cpmp/bpwg/3226/99 cpmp/bpwg/283/00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cpmp ad-hocwerkgroep bloedproducten referentienummer cpmp/ bpwg/ 2220/ 99
cpmp-ad-hoc-arbeitsgruppe blutprodukte dokumentennummer cpmp/bpwg/2220/99
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
emea/cpmp/ewp/1776/99 cpmp/bpwg/602/95 rev.
emea/cpmp/ewp/1776/99 emea/cpmp/602/95 rev.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/bpwg/1561/99 emea/cpmp/phvwp/bpwg/
emea/cvmp/344/99
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
